Global University Venturing

New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.

Samsung is reportedly eyeing Tel Aviv University-founded smartphone camera technology developer Corephotonics for $150m to $160m after backing its series B and C rounds.

Toronto’s AmacaThera is preparing clinical trials of a drug delivery hydrogel that could diminish the need for prescription opioid painkillers after surgery.

Strathclyde-founded dermatological device manufacturer Cutitronics has collected further investment from specialty chemicals supplier Croda as the pair aim to win business with personal care brands.

The university has helped launch 223 businesses, including 130 based on its IP, since an overhaul of its commercialisation strategy in 2013.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Christine Gulbranson, chief innovation officer of University of California, outlines the changes her institution has enacted to support the innovation ecosystem.

Nanomaterials provider Nanogap, a spinout of University of Santiago de Compostela, received $2.1m from Repsol's Corporate Venture vehicle.

Microsoft, Bridgestone and Qualcomm all contributed to a series D round for MIT spinout ClearMotion, which emerged from stealth earlier last year with $130m in funding.

MIT molten metal production spinout Boston Metal has drawn funding from the Engine in its first publicly disclosed funding round.

University of Cambridge flow sensor spinout Flusso was previously backed by the university’s Cambridge Enterprise tech transfer office in June 2017.